
ACCELERON PHARMA INC
Share · US00434H1086 · XLRN · A1W5LE (XNMS)
No Price
n/a
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
- | - | - | - | 0,00 % | 0,00 % | 95,27 % |
Company Profile for ACCELERON PHARMA INC Share
Acceleron Pharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. It offers luspatercept-aamt for the treatment of anemia in adult patients with beta-thalassemia under the REBLOZYL name. The company also develops luspatercept-aamt for the treatment of myelodysplastic syndromes and myelofibrosis; Sotatercept for the treatment of patients with pulmonary arterial hypertension; and ACE-083, a neuromuscular candidate that is in Phase II clinical trials for the treatment of patients with Charcot-Marie-Tooth disease. In addition, it has a collaboration, license, and option agreement with Celgene Corporation; and collaboration and license agreement with Fulcrum Therapeutics, Inc. to identify small molecules designed to modulate specific pathways associated with a targeted indication within the pulmonary disease space. The company was formerly known as Phoenix Pharma, Inc. Acceleron Pharma Inc. was founded in 2003 and is headquartered in Cambridge, Massachusetts.
Invested Funds
The following funds have invested in: ACCELERON PHARMA INC invested:
Fund | Vol. in million 264,86 | Percentage (%) 0,62 % |
Company Data
Name ACCELERON PHARMA INC
Company Acceleron Pharma Inc.
Symbol XLRN
Website
http://www.acceleronpharma.com
Primary Exchange
NASDAQ/NMS (GLOBAL MARKET)
WKN A1W5LE
ISIN US00434H1086
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mr. Habib Dable
Country United States of America
Currency USD
Employees 0,3 T
Address 128 Sidney St, 02139 Cambridge
IPO Date 2013-09-18
Ticker Symbols
Name | Symbol |
---|---|
NASDAQ | XLRN |
More Shares
Investors who ACCELERON PHARMA INC hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.